Search research articles
Contact Us
Filters
Showing results (61-70 of 73) with videos related to
Page
of 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs
E M Fielden, G E Adams, S Cole, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
October 5, 2001
Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement
J E Gaugler, A B Edwards, E E Femia, et al.
Journal of Medicinal Chemistry
|
September 18, 1992
2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives
M A Naylor, M D Threadgill, P Webb, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
August 1, 1974
Letter: A synergistic interaction between u.v. and protons in causing loss of reproductive capacity in Escherichia coli B-r
G J Neary, D A Bance, R Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)
A V Patterson, N Robertson, S Houlbrook, et al.
Drug Design and Discovery
|
January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro
M A Naylor, M D Threadgill, H D Showalter, et al.
Anti-Cancer Drug Design
|
December 1, 1993
Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines
M A Naylor, M A Stephens, J Nolan, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
M A Naylor, M A Stephens, S Cole, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
M D Threadgill, P Webb, P O'Neill, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 73) with videos related to
Sort By:
Page
of 8
International Journal of Radiation Oncology, Biology, Physics
|
January 1, 1992
Assessment of a range of novel nitro-aromatic radiosensitizers and bioreductive drugs
E M Fielden, G E Adams, S Cole, et al.
The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences
|
October 5, 2001
Predictors of institutionalization of cognitively impaired elders: family help and the timing of placement
J E Gaugler, A B Edwards, E E Femia, et al.
Journal of Medicinal Chemistry
|
September 18, 1992
2-Nitroimidazole dual-function bioreductive drugs: studies on the effects of regioisomerism and side-chain structural modifications on differential cytotoxicity and radiosensitization by aziridinyl and oxiranyl derivatives
M A Naylor, M D Threadgill, P Webb, et al.
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine
|
August 1, 1974
Letter: A synergistic interaction between u.v. and protons in causing loss of reproductive capacity in Escherichia coli B-r
G J Neary, D A Bance, R Cox, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 1994
The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)
A V Patterson, N Robertson, S Houlbrook, et al.
Drug Design and Discovery
|
January 1, 1993
Synthesis of the enantiomers of the bioreductively-activated cytotoxin RSU-1069 and its prodrug RB6145 and lack of stereoselectivity in their cytotoxicity and radiosensitization in vitro
M A Naylor, M D Threadgill, H D Showalter, et al.
Anti-Cancer Drug Design
|
December 1, 1993
Heterocyclic mono-N-oxides with potential applications as bioreductive anti-tumour drugs: Part 1. 8-Alkylamino-substituted phenylimidazo [1,2-a] quinoxalines
M A Naylor, M A Stephens, J Nolan, et al.
Journal of Medicinal Chemistry
|
September 1, 1990
Synthesis and evaluation of novel electrophilic nitrofuran carboxamides and carboxylates as radiosensitizers and bioreductively activated cytotoxins
M A Naylor, M A Stephens, S Cole, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
Journal of Medicinal Chemistry
|
July 1, 1991
Synthesis of a series of nitrothiophenes with basic or electrophilic substituents and evaluation as radiosensitizers and as bioreductively activated cytotoxins
M D Threadgill, P Webb, P O'Neill, et al.
Page
of 8